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ABSTRACT 
Clostridium difficile infection is a major cause of nosocomial diarrhoea, and can culminate in the life-
threatening conditions pseudomembranous colitis and toxic megacolon.  Disease is produced in C. 
difficile infection through the release of toxin A and toxin B.  Current diagnostics rely on a combination 
of immunoassays, histopathological findings, and PCR.  Immunoassays, though fast, lack sensitivity 
compared to more expensive and time-consuming histopathology methods.  PCR, though sensitive, 
only indicates the presence of toxin genes and not whether they are being expressed.  Matrix Assisted 
Laser Desorption/Ionization Time-of-Flight mass spectrometry (MALDI-TOF) has been gaining 
popularity in medical laboratories as a means of identifying bacterial isolates due to high sensitivity 
and fast turnaround time. The purpose of this study is to investigate MALDI-TOF as a means of 
detecting the presence of C. difficile toxins A and B.  The method developed was based on the 
proposed cellular processing mechanism of toxin A and B – both are large toxins (approximately 300 
kDa) that are endocytosed and undergo a pH-induced conformation change in the early endosome.   
This causes the active domain and protease domain of the toxin to be  translocated into the cytoplasm.  
Inositol hexakisphosphate, an abundant cystosolic signaling molecule, then binds to the protease 
domain of the toxin and induces the release of the 63 kDa active toxin.  The active component of both 
toxin A and B glucosylates cellular Rho GTPases, which results in cytoskeleton derangement and cell 
death.  The method developed required fecal material to be prepared as a 1:10 dilution in deionized 
water followed by filter sterilization.  The filtrate volume was then divided into two equal volumes, and 
each volume was subjected to an acetonitrile precipitation.  One pellet was resuspended in deionized 
water, and the other in sodium acetate buffer (100mM, pH 4.7) to mimic the conditions of the early 
endosome. The spectra produced from each condition were overlaid, which demonstrated the presence 
of a high-intensity peak at approximately 60 kDa in known toxin positive specimens.  If this peak can 
be shown to be correlated to the presence of toxin in a larger sample set, this method may hold promise 
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as a means of detecting C. difficile toxins A and B.  This protocol avoids the extensive time and labour 
associated with a mass-fingerprinting approach, while maintaining higher degree of specificity than 
simple intact protein detection due to the comparison of spectra between acid and neutral conditions. 
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INTRODUCTION 
Clostridium difficile is a Gram positive, sporogenous nosocomial pathogen of increasing concern due to 
the potential severity of disease produced, and because of the difficulty in controlling the spread of 
infection due to the persistence of spores in the environment.  Infection is associated with antibiotic 
use, which is believed to sufficiently disrupt normal enteric flora to allow C. difficile overgrowth 
(Bartlett 2002).  Pathologic effects are mediated entirely through the release of toxins, and only strains 
that possess the 19.6 kb pathogenicity locus are capable of producing disease (Braun et al 1996).  Toxin 
A and toxin B  are encoded by tcdA and tcdB found within the pathogenicity locus, and are classified as 
Large Clostridial Toxins (LCTs) because of their respective sizes, 308 and 270 kDa (von Eichel-
Streiber et al 1992).  Typically these toxins are both present in infection, though each is able to cause 
cytopathic effects individually with toxin B being approximately 1000 times as potent as toxin A 
(Chaves-Olarte et al 1997).  Toxin A and toxin B have a homologous structure and are composed of 
four discrete domains, each with a distinct role in cellular processing – the  A (active), B (binding), C 
(cutting) and D (delivery) domains (Jank and Aktories 2008).   
 
 
 
 
 
 
 
 
 
Figure 1. Domain organization of Clostridium difficile toxins A and B. Taken from Davies et al 2011. 
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The B (binding) domain of the toxin binds to epithelial cell surface carbohydrates, and the toxin is 
internalized (Tucker and Wilkins 1991; Florin and Thelestam 1983).  Next, a drop in pH in the early 
endosome induces the toxin to insert the hydrophobic delivery domain (D) into the endosomal 
membrane to form a channel, which allows the active (A) and cysteine protease (C) domains to 
translocate across the endosomal membrane (Barth et al 2001; Qa’dan et al 2000). Cytosolic inositol 
hexakisphosphate (InsP6) then binds to the C domain, presumably as an allosteric switch, and induces 
autocleavage and release of the active toxin (Egerer et al 2009).  The active toxin then acts as a Rho 
GTPase glucotransferase, which results in the depolymerization of actin fibers leading to cytoskeleton 
derangement and cell death (Just et al 1995).  Severity of disease is dependent on host factors and on 
the strain of C .difficile involved, and can range from mild diarrhoea to the medical emergencies toxic 
megacolon and pseudomembranous colitis (Rupnik et al 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Cellular processing pathway of large clostridial toxins. Taken from 
Davies et al 2011.  
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Conventional diagnostic methods typically involve algorithms composed of immunoassays, 
histopathological findings and/or PCR.   Protocols and assays used tend to vary considerably between 
different laboratories. Cytotoxic assays are the original gold standard of C. difficile toxin detection, and 
involve inoculating tissue monolayers with fecal supernatant and observing for cytopathic effects.  Also 
used as a gold standard is cytotoxigenic culture, wherein fecal samples are selectively cultured for C. 
difficile and cultural supernatant is used to inoculate tissue monolayers. The major drawback to both 
gold standards is time (up to 48 hours for cytotoxic assays and up to 72 hours for cytotoxogenic 
culture) and expense (Eastwood et al 2009).  As well, the exact protocol and cell lines used tend to vary 
between laboratories.  Immunoassays specific for toxin A and/or toxin B have been widely adopted in 
clinical laboratories due to ease of use and relatively fast turnaround times, but they lack sensitivity 
compared to tissue culture standards.  Rene et al (2012) evaluated eight commercial immunoassays and 
recorded sensitivities of 31.7 -55.2% compared to cytotoxic/cytotoxigenic standards.  C. difficile 
antigen testing is performed in some laboratories, either as an initial screening test or as a combined 
antigen/toxin immunoassay.  The antigen is a 46 kDa glutamate dehydrogenase (GDH) that typically 
exists as a high molecular weight aggregate, and is abundantly and constitutively expressed by both 
pathogenic and non-pathogenic C. difficile strains (Lyerly et al 1991).  PCR has gained popularity as a 
diagnostic tool due to its high sensitivity and fast turnaround time. However, although PCR possesses 
high sensitivity, it has a somewhat lower positive predictive value – Novak-Weekley et al (2010) found 
PCR (Xpert C. difficile assay) to have a sensitivity of 94.4% and a positive predictive value of 84% 
when compared to toxigenic culture.  The implication of these findings is that PCR is prone to the 
production of false positives – this is a predictable conclusion, due to the fact that PCR only detects the 
potential for toxin production (the presence of toxin genes) rather than the presence of the toxins.  As 
well, C. difficle toxins are believed to be produced through a quorum sensing mechanism rather than 
constitutively, which lends further credence to the notion that the presence of toxin genes in enteric 
specimens is not a conclusive indication of C. difficile infection (Darkoh 2012).  Early diagnosis of C. 
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difficile infection offers the best prognosis to the afflicted patient (Kelly&Lamont 1998), and so there is 
a need for an assay that demonstrates the presence or absence of toxin that combines the virtues of high 
sensitivity and fast-turnaround time. 
 
Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF) is a 
soft ionization technique that characterizes molecules based on their mass-to-charge ratio.  Analyte 
molecules are cocrystallized in an organic acid matrix, which facilitates the ionization and desorption 
of the analyte when subjected to UV laser irradiation.  The charged, gaseous analyte is then propelled 
by an electric field through a vacuum until it reaches a detector plate.  The size of an ion is determined 
by the time it takes to reach the detector plate – the smaller the ion, the faster it will reach the detector 
plate.  Proteins are typically identified with MALDI-TOF using mass fingerprinting, which consists of 
characterizing a protein based on the peptide set it produces when subjected to digestion.  Since trypsin 
and other proteases used for this purpose cleave at specific residues, a characteristic set of fragments is 
produced that can be used to unambiguously identify the protein of interest (MALDI-TOF peptide and 
protein analysis is reviewed by Lewis et al 2000).   
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Schematic of the MALDI-TOF ionization and detection process.  After laser 
irradiation and desorption, analyte molecules separate based on size as they travel towards the 
detector.  Linear mode detection is used for larger (>20 kDa) proteins, and reflectron mode is 
used for smaller (<20 kDa) analye molecules.  Taken from the Radbound University Nijmegen 
website http://www.ru.nl/science/gi/facilities/other-devices/maldi-tof/. 
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This approach has been used successfully in the past to characterize LCTs (van Baar et al 2004).  
However, a mass fingerprinting approach has several drawbacks to large scale application in a clinical 
laboratory: first, a conventional tryptic digest takes approximately 12 hours to perform; second, 
preparation of samples from biological materials for digestion requires many steps to sufficiently purify 
and denature the protein of interest (van Baar et al 2004; Colquhoun et al 2006).  Lastly, agents used to 
prepare the protein for the digestion process can interfere with the crystallization and ionization process 
and require removal before MALDI analysis.  An alternative to mass fingerprinting is to simply detect 
the intact protein.  Although this approach avoids the extensive preparation required for mass 
fingerprinting, it has two major shortcomings.  One is that a protein cannot be unambiguously 
identified in this manner, since all that will be determined is the mass of the protein.  The second is that 
MALDI is not well suited to detecting larger proteins (>100KDa) - larger proteins do not ionize as 
efficiently, and the peaks produced are much broader (van Remoortere et al 2010).   These two 
problems can be addressed by taking advantage of the biology of C. difficile toxins; toxin A and B both 
undergo autocatalysis to produce a 63 kDa active toxin, which is a more amenable to MALDI detection 
than the approximately 300 kDa holotoxins.  As well, autocleavage occurs under specific conditions, 
which can be mimicked to add specificity to the method.    
 
Inducing autocatalysis in toxin A and B has previously been performed using dithiothreitol (DTT), 
InsP6, or both (Egerer et al 2007; Egerer et al 2009; Reineke et al 2007).  DTT is a well-known 
activator of cysteine proteases, and has a synergistic effect when used in combination with InsP6 on the 
autocleavage efficiency of C. difficile toxins (Egerer et al 2007).  In previous studies, cleavage assays 
have been performed at a neutral pH.  However, the change in conformation described by Qa’dan et al 
(2000) to a form presumably more conducive to autocleavage occurs at pH 4-5. In this study, it was 
theorized that adjusting the sample to pH 4-5 would produce conformational changes in the toxins that 
would enhance autocleavage upon the addition of InsP6, DTT, or a mixture of InsP6 and DTT.  
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Fecal material is arguably the most difficult biological fluid to analyze due to an abundance of 
microorganisms, intestinal cells, bile acids and other lipids, and undigested material that could interfere 
with protein analysis (Oleksiewicz et al 2005).  However, despite the seemingly heterogeneous and 
complex nature of fecal material, Wu et al (2007) found that MALDI spectra were surprisingly simple 
and uniform between individuals in the 10-20kDa detection range (higher mass ranges were not 
examined in this study). 
 
 In this study, the efficacy of a variety of autocleavage conditions were tested on both pure toxin A as 
well as clinical fecal specimens to determine if the autocleavage event could be detected by comparing 
the region in the MALDI spectrum corresponding to the size of the active toxin (55-65 kDa) between 
samples before and after treatment. 
 
MATERIALS AND METHODS 
Biosafety considerations 
 Due to the sporogenous nature of C. difficile, special precautions were taken to prevent 
 contamination of the work area.  The study was carried out in a containment level 2 laboratory,  
 and all work was conducted inside a biological safety cabinet using dedicated equipment.  
 Pipette tips used to process clinical specimens were immersed in 10000 ppm Precept for at least 
 ten minutes after use, and the biological safety cabinet was decontaminated with 2% Virkon 
 after each use.  The MALDI target plate was cleaned by first wiping with water and then 
 propanol, followed by ultrasonication for ten minutes in propanol followed by TA30.  Fecal 
 material remaining after analysis and all disposable material used were autoclaved before 
 disposal.   
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Materials 
 Acetylated Bovine Serum Albumin (BSA) was purchased from Promega, lyophilized pure 
 C. difficile toxin A was purchased from List Biologicals, and sinipinnic acid matrix was 
 purchased from Bruker Daltonics.  Blunt fill needles, 0.22 micron filters, and 5 cc syringes were 
purchased from BD Canada. Reagents (sodium acetate, glacial acetic acid, anhydrous ethanol, 
trifluoroacetic acid, acetonitrile) were supplied by the Thompson Rivers University Chemistry 
and Biology departments.   
Optimization of MALDI parameters and matrix selection 
 A saturated solution of sinapinnic acid in TA30 (3:7 HPLC grade acetonitrile:0.1% 
trifluoroacetic acid in water) prepared in the dried droplet method was used as a matrix, and a 
ground steel plate was used as a target.  The dried droplet method simply involved placing 0.5 
µL of matrix onto the target plate, followed by the addition of  0.5 µL of sample.  The 1 µL 
volume was then mixed briefly by pipetting, and allowed to dry.  Linear positron mode was 
used, and the detection range was 15-75 kDa. Laser intensity was set at 85%, and the laser was 
set to fire 100 shots in a random pattern.  This was performed at five different locations on the 
target for a total of 500 shots per sample.  BSA (0.1 µg/µL) was spotted with each batch of 
samples to ensure matrix integrity.  Protein Standard II (Bruker Daltonics) was used as a 
calibrant, and was spotted onto the plate after each cleaning.   
Induction of autocleavage in pure toxin 
 Pure toxin A (2 µg) was reconstituted in 100 µl of deionized water as per the specification sheet 
provided by List Biologicals.  The pure toxin had been lyophilized with resuspension buffer 
components to form concentrations of 50mM NaCl and 50mM Tris when 100 µl of water was 
added.  Four different conditions were applied to investigate which produced the desired 
autocatalytic effect, and were composed of combinations to produce final concentrations of 
DTT 2 mM and InsP6 5 mM.  Conditions tested were deionized water, DTT, InsP6, and a 
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mixture of DTT and Insp6.  All conditions were allowed to incubate for 5, 10, 20, and 60 
minutes before being spotted.   
 
Clinical Specimens 
 Stool specimens from suspected C. difficile infection cases were collected by Royal Inland 
Hospital (RIH) staff.  After testing using the C.diff Quik Chek Complete® immunoassay 
(Techlab), the remainder of the specimen was stored at -80ºC until the commencement of the 
project.  Each specimen was assigned a number, and the immunoassay results for each 
specimen were recorded by RIH staff onto a master list (C. difficile antigen/toxin 
positive/negative).  Upon receipt, specimens were allowed to thaw and immediately processed.  
Approximately 100µl of fecal specimen was diluted ten times in deionized water and filter 
sterilized with a 0.22 micron syringe filter in accordance with the method of fecal sample 
preparation for toxin detection outlined by O’Connor et al (2001).  The filtrate was then split 
into two equal volumes.  To each volume of filtrate one volume of HPLC grade acetonitrile was 
then added, vortexed for 5 seconds, and allowed to incubate at room temperature for 20 
minutes.  The sample pair was then centrifuged at 10000 rpm for 10 minutes at room 
temperature in a bench top centrifuge, and the supernatant poured off.  One pellet was then 
resuspended in 200 µL deionized water, and the other in 200 µL sodium acetate (100 mM, pH 
4.7).  Spots were made from each suspension condition.   The samples were then analyzed using 
MALDI-TOF. 
RESULTS 
Pure toxin 
 The attempted induction of autocatalysis in pure toxin A did not provide any clear signals.  It 
was suspected that buffer contamination may have interfered with MALDI analysis, and so 
protein precipitation was attempted using 0.1% TFA in HPLC grade acetonitrile as per Hamrita 
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et al (2012). The mixture was allowed to incubate at room temperature for 30 minutes, and then 
was centrifuged at 10 000 rpm for 10 minutes.  Autocatalysis conditions were once more tested, 
and no signals were produced. 
 
 Table 1. Effect of autocleavage conditions and incubation time on the presence of peaks in the 55-65k Da region 
 for pure toxin A. 
Peak between 55 and 65 kDa present/absent  
 
Autocleavage Condition 
5 minutes 10 minutes 20 minutes 60 minutes 
DTT (2 mM) absent absent absent absent 
InsP6 (5 mM) absent absent absent absent 
DTT (2 mM) and Insp6 (5 mM) absent absent absent absent 
Deionized water only absent absent absent absent 
 
Clinical specimens  
Initially, clinical specimens were diluted ten times in water and filtered through a 0.22 µm 
syringe filter.  Matrices were prepared as a double layer as was suggested in the Bruker 
Daltonics user’s manual for the detection of intact proteins.  This involved spotting 0.5 µm of 
ethanol saturated with sinapinnic acid onto the target, allowing it to dry, and then spotting of a 
1:1 mixture of TA30 saturated with sinapinnic acid and sample on top. The spectra produced 
were poor-quality, and were highly variable between spots from the same sample.  Unsuitable 
matrix composition was suspected as a potential cause for lack of consistency between spots 
from the same sample, and so a dried droplet method was attempted instead.  An aliquot of 0.5 
µL of TA30 saturated with sinapinnic acid was spotted onto the target, to which 0.5 µL of 
sample was added and briefly mixed by pipetting.    The dried droplet method produced more 
 15 
consistent spectra between shots with less background noise.  However, even with the dried 
droplet producing an improvement in the clarity of the spectra, peaks were still poorly resolved.  
It was theorized that lipid contamination may have been to blame, which can cause poor matrix 
cocrystallization (Wu et al 2007).   The addition of one volume of acetonitrile followed by 
incubation for 20 minutes and precpitation via centrifugation at 10000 rpm on a benchtop 
centrifuge for 10 minutes was added to the protocol to remove hydrophobic contaminants, 
which drastically improved the quality of the spectra.  Once intelligible spectra were produced, 
the induction of autocleavage was attempted.  Precipitate was resuspended in both deionized 
water and sodium acetate (100 mM, pH 4.7). Baseline spots were taken, and DTT (2 mM final 
concentration) or a mixture of  DTT and InsP6 (2 mM, 2 mM final concentration) were added to 
each resuspension condition.  Samples were spotted after 30 minutes of incubation, and an 
intensity reading of greater than 500 was decided as indicating the presence of a peak due to the 
height of the baseline in raw spectra. 
 
 Table 2. Effect of clinical precipitate resuspension conditions on the presence of peaks in the 55-65kDa region. 
Resuspension Condition Peak between 55 and 65 kDa 
present/absent  
(intensity reading > 500) 
Deionized water absent 
Deionized water,  DTT (2 mM) absent 
Deionized water,  DTT (2 mM), InsP6 (2 mM) absent 
Sodium acetate buffer (pH 4.7) present 
Sodium acetate buffer (pH 4.7), DTT (2 mM) absent 
Sodium acetate buffer (pH 4.7), DTT (2 mM), InsP6 (2 mM) absent 
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The addition of DTT or DTT and InsP6 seemed to have decreased the quality of the spectra, and 
the presence of a peak corresponding to the size of the autocleavage product was not detected in 
the post-incubation spectra.  However, when pre-incubation spectra from sodium acetate and 
water resuspension were overlaid from the same sample, there was a distinct, high-intensity 
peak present in the acidic solution not present in its water counterpart corresponding to a weight 
of approximately 56-60 kDa.   
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Figure 4. Comparison of known toxin (+)  samples resuspended in  100 mM sodium acetate, pH 4.7  pre (red) and post-
treatment with 2 mM DTT (green) and 2mM DTT+2mM InsP6 (pink). Two different samples shown.  
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Figure 5. Comparison of known antigen(+)/toxin (+) samples resuspended in deionized water (blue) and 100 mM 
sodium acetate, pH 4.7 (red). Two different samples shown. 
Figure 6. Comparison of known antigen (-)/toxin (-) samples resuspended in deionized water (blue) and 100 mM 
sodium acetate, pH 4.7 (red). Two different samples shown. 
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The 56-60 kDa peak was not detected in known toxin-negative samples tested.  However, one known 
antigen-positive/ toxin-negative sample was tested, which did demonstrate the presence of a peak 
between 56-60 kDa. 
 
Despite the complex and heterogeneous nature of fecal material, spectra in the 15-75kDa range were 
remarkably similar between samples tested.  This is similar to the findings of Wu et al (2007), wherein 
they examined the MALDI spectra in the 10-20 kDa range of feces spiked with haemoglobin from 
donors with unrestricted diets.   
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Figure 7a. Comparison between known antigen(+)/toxin (+) samples (red,green) and a known antigen (+) /toxin (-) 
sample (black). 7b. Comparison between known antigen(-)/toxin(-) samples (red,green) and a known  
antigen (+)/toxin(-) sample (black). 
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DISCUSSION 
Initially, a mass fingerprinting approach was investigated as a means of demonstrating the presence of 
toxin A and B.  As discussed previously, the time-consuming and labour intensive conventional mass 
fingerprinting approach was deemed impractical for use in the clinical laboratory, and so alternatives 
were sought to decrease time and effort required for sample identification.  The longest step of the 
process, tryptic digestion, was targeted first.  There are many modifications that can be used to 
decrease digestion time, though ultrasonic-assisted digestion appeared to be the most promising for 
several reasons: it is fast, with reports of complete digests being performed in as little as 40 seconds 
(Lopez-Ferrer et al 2005); it is easy to perform, and it is well suited to automation.  The next 
modification investigated was abridgement of the conventional protein preparation procedure – 
typically, protein digestion involves protein denaturation with a chaotropic agent, disulfide bridge 
reduction, cysteine residue alkylation, and removal or dilution of chaotropic agents (van Baar et al 
2004).  These steps require several hours to complete, and so an alternative attempted was to 
dramatically simplify the procedure.  Acetonitrile in water in a 4:1 ratio was used as a denaturant, as it 
was found by Strader et al (2005) to be an effective substitute for chaotropic agents and is compatible 
with MALDI analysis.  As well, disulfide bond reduction and cysteine residue alkylation may not be 
required for digestion for all proteins (Lopez-Ferrer et al 2005).  BSA was used to test digestion 
modifications, and a peptide set was produced that was identifiable as BSA using the simplified method 
with an overnight digestion in 4:1 acetonitrile in water with a 1:20 protease ratio.  No successful 
digestions were produced using ultrasonic assistance along with a simplified protein preparation 
method.  Mass fingerprinting was eventually abandoned as a means of protein identification due to the 
increasing number of expensive and time-consuming alterations that would be required to apply this 
method to analyzing fecal material, such as the use of immobilized trypsin, desalting filters, and  
potentially affinity purification.  Though mass fingerprinting has been used to successfully identify 
proteins from pathogenic organisms in feces (Colquhoun et al 2006), the intention of this study was to 
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investigate the development of an assay comparable in turnaround time and ease of implementation to 
currently used enzyme immunoassays.  
  
An autocleavage-based assay was investigated instead due to its relative simplicity and sturdiness 
compared to mass fingerprinting.  Mass fingerprinting has many more steps, and so more potential for 
error in proper execution of each process.  As well, a mass fingerprinting method is more prone to 
erroneous results due to contamination – in intact protein detection, a high-abundance contaminant 
would appear as a distinct peak; in mass fingerprinting, a high abundance contaminant would be 
digested alongside the protein of interest to produce a peptide spectra characteristic of neither.  An 
advantage of a peptide mass fingerprinting is that it is considerably more sensitive than intact protein 
detection – larger mass proteins ionize with lower efficiency, and therefore must be present in higher 
quantities to be detected. The lowest limit of detection for intact proteins in blood samples for MALDI-
TOF is typically >1 µmol/L, though this can vary considerably based on the size of the protein, its 
particular ionization efficiency, preparation methods, and signal suppression from the presence of other 
ions (Hortin 2006).  The same may apply to fecal matter.  The precipitation step in the method 
described in this study may help to partially compensate for reduced sensitivity at higher mass ranges.  
100 µL of fecal material and 200 µL of water or sodium acetate for resuspension were arbitrarily 
chosen volumes – increasing the amount of fecal material used while decreasing the resuspension 
volume could concentrate the toxins, and increase the limits of sensitivity. 
 
An omnipresent issue with MALDI is the effect of reagents and buffers on the cocrystallization process 
– final concentrations of reagents used were based on studies wherein successful pH induced  
 
conformation change/autocleavage of toxin had been induced (Qa’dan et al 2000; Egerer et al 2009; 
Reineke et at 2007), and were checked against the MALDI TOF buffer concentration tolerance chart 
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available on the UBC ChiBi website (see Appendix 1).  Though the DTT concentration used was well 
below the suggested maximum concentration, a decrease in spectra quality was observed.  This may 
have been due to this chart presumably applying to pure, low mass analysis, as this is typically what 
MALDI is used for – the ionization kinetics for high mass proteins in a complex sample may be 
sufficiently different be affected by concentration of reagents considered reasonable for lower mass 
analysis.  No information was found for suggested concentrations of InsP6 for MALDI-TOF analysis.  
The original design of this experiment involved comparing samples pre-and post-treatment; however, 
treatment seemed to significantly reduce the quality of the spectra.  Instead, an alternative to this 
approach that arose during the course of this investigation was to compare precipitate resuspended in 
water to precipitate resuspended in sodium acetate.  Not only does this method produce better quality 
spectra, but it is also faster than the previous method design.  The peak produced corresponds to a 
smaller size than the expected autocleavage product (56-60 kDa compared to 63kDa) – it is possible 
that the active toxin may undergo a previously unidentified protein modification post-cleavage or 
predictable fragmentation during the ionization process, though this is just speculation.  Unfortunately, 
no spectra were obtained from the attempted induction of autocleavage of pure toxin A to be used for 
comparison’s sake.  It is possible that buffer and experimental conditions interfered with the production 
of useable spectra, that the toxin had been degraded during storage or transport, or that autocleavage 
was not successfully induced.  Interestingly, no peaks were present in the 55-65 kDa range for toxin 
negative samples, whereas the antigen positive/toxin negative sample demonstrated a peak neatly 
corresponding with the high intensity peak produced from toxin positive samples.  It is possible that 
toxin was present in this sample, but was not detected with the immunoassay – if this were the case, 
then this protocol may hold potential as a higher sensitivity alternative to C. difficile toxin 
immunoassays. 
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Aside from the detection of toxin A and B, examining the 15-75 kDa mass range may allow the 
detection of a third C. difficile toxin (binary toxin) as well as other proteins secreted by C. difficile 
during toxin production.  Although binary toxin alone is not suspected to cause disease, infection with 
strains possessing all three toxins has a higher case-fatality rate than infection with strains only capable 
of toxin A and B production, indicating that binary toxin may potentiate toxins A/B or act as a 
virulence marker (Bacci et al 2011).  Binary toxin is composed of two independently produced 
proteins, with masses of 48 kDa and 94 kDa (Goncalves et al 2004).  As well, Mukherjee et al (2002) 
demonstrated the secretion of a number of proteins by pathogenic C. difficile in the mass ranges of 24-
50 kDa.   
 
Despite the potential this assay presents, there are some shortcomings to consider. The method 
proposed does not lend itself well to quantification.  The aliquot of fecal material used can only be 
roughly 100 µL due to variations in consistency of fecal material, which also affects the final volume 
of filtrate.  As well, MALDI is not inherently well suited to quantification studies due to matrix 
heterogeneity – that is, analyte molecules will crystallize in different concentrations in different parts of 
the matrix, and so signal intensity may vary considerably between shots (Szajli et al 2008).  It is 
possible to create a standard curve for a given analyte of interest, and to take a sufficiently large 
number of shots to compensate for matrix heterogeneity.  However, standard curves would be best 
applied to pure samples rather than complex ones – differences in fecal composition between 
individuals could foreseeably affect matrix cocrystallization, and therefore the relative intensities 
generated from a sample.  Although technical hurdles exist to quantification, it is not a pressing 
concern due to the primarily qualitative nature of C. difficile infection diagnosis – all that is required is 
the detection of toxin coupled with clinical manifestations for the diagnosis of C. difficile infection 
(Bouza 2005).   
The significance of the ~60 kDa peak present in precipitate resuspended under acidic conditions, along 
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with other peaks present in toxin positive samples in the 15-75 kDa range, needs further investigation.  
Many more samples need to be tested to determine if the presence of the peak is correlated to the 
presence of toxin.  If there does turn out to be a correlation, the identity of the ~60 kDa peak would 
need to be confirmed through Western blotting. 
If results obtained indicate that this method may be a viable assay, information such as sensitivity, 
specificity, accuracy, positive predictive value, and negative predictive value when compared to a gold 
standard will need to be determined.  As well, appropriate storage conditions and testing timeframes for 
this assay need to be tested.   
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APPENDIX 
Tolerances of MALDI TOF MS to buffer components and 
contaminants 
Maximum Allowable Concentration 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taken from the UBC Centre for High-Throughput Biology (CHiBi) website 
(http://www.chibi.ubc.ca) 
 
Component  Maximum 
Concentration 
Ammonium Acetate 500 mM 
Ammonium 
Bicarbonate 
250 mM 
CAPS 200 mM 
Dithiothreitol (Dtt) 500 mM 
EPPS 250 mM 
Glycerol 1% v/v 
Glycine 500mM 
Guanidine-HCl 500 mM 
HEPES 100 mM 
Imidazole 250 mM 
